RiverVest Venture Management’s Mirum Pharmaceuticals MIRM Stock Holding History

RiverVest Venture Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,621,118	Closed	-$41.9M	–	6
2023 Q2	$41.9M	Hold	1,621,118	–	–	46.52%	1
2023 Q1	$38.9M	Hold	1,621,118	–	–	45.05%	1
2022 Q4	$31.6M	Sell	1,621,118 -300,000	-16%	-$5.93M	36.87%	2
2022 Q3	$40.4M	Hold	1,921,118	–	–	46.86%	1
2022 Q2	$37.4M	Hold	1,921,118	–	–	54.94%	1
2022 Q1	$42.3M	Hold	1,921,118	–	–	43.43%	1
2021 Q4	$30.6M	Hold	1,921,118	–	–	21.86%	2
2021 Q3	$38.3M	Hold	1,921,118	–	–	6.43%	2
2021 Q2	$33.2M	Hold	1,921,118	–	–	6.49%	2
2021 Q1	$38.1M	Hold	1,921,118	–	–	5.86%	2
2020 Q4	$33.5M	Buy	+1,921,118	New	+$37.8M	3.68%	3

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RiverVest Venture Management's MIRM Position: Q3 2023 in Review

RiverVest Venture Management sold out of Mirum Pharmaceuticals (MIRM) in Q3 2023, closing a stake of 1,621,118 shares — an estimated $41.9M sold.

RiverVest Venture Management first reported a position in MIRM in Q4 2020 and held it in 11 quarters. The position peaked at $42.3M in Q1 2022. 159 funds tracked by Wall St. Rank hold MIRM as of Q3 2023.

RiverVest Venture Management reported no remaining Mirum Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
RiverVest Venture Management sold 1,621,118 Mirum Pharmaceuticals shares in Q3 2023, an estimated $41.9M.
RiverVest Venture Management first reported a position in Mirum Pharmaceuticals in Q4 2020 and held it in 11 quarters.
RiverVest Venture Management's Mirum Pharmaceuticals position peaked at $42.3M in Q1 2022.
159 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2023.

Based on RiverVest Venture Management's 13F filing for Q3 2023, filed 30 Oct 2023.